After median follow up of 60 months, in single positive lymph node patients, 3 patients died due to prostate cancer, 6 patients had clinical progression of metastasis, and 20 patients had BCR and 16 patients remained with no recurrence (biochemical and clinical). This evidence concerns the gene BCR and Familial prostate cancer.